Editorial
 NEW PATH LAB RULES WEAK   
 Wednesday, October 10, 2018 
 Regulating pathology labs in the country has run into a serious mess now with the notification of the Clinical Establishments Amendment Rules from May 18, 2018 by the Union health ministry. 
  Past Editorial...  
TODAY'S NEWS
16:00  [IST]Sysmex Inostics' study in Journal of Molecular Oncology highlights clinical value of blood-based ctDNA mutation testing in melanoma treatment
15:50  [IST]Medlife awarded India’s best pharma delivery e-Platform company by Frost and Sullivan in 2018
15:40  [IST]Mylan Pharmaceuticals attracts 200 participants from 44 cities for its Hackathon event to address health challenges
15:00  [IST]Bluegrass Vascular completes enrollment of international SAVE registry with positive results
14:00  [IST]Premier Health Group selects Reliq Health Technologies as technology partner for their HealthVue Clinics
13:00  [IST]Hemogenyx's subsidiary Immugenyx inks collaboration deal with Janssen Research & Development
more news >>
TOP NEWS
08:00  [IST]J&J faulty hip implant patients not to participate in compensation process in its present form, write to Nadda
08:00  [IST]Experts advocate Indian cos to adopt Indian certification to address product compliance in domestic and int’l mkt
08:00  [IST]Karnataka drugs control dept with 38 Pharm D colleges to support to ADR monitoring
08:00  [IST]Health ministry creates post for Pharm D pass out in AIIMS; other govt hospitals can adopt model: Dr TV Narayana
08:00  [IST]IPA AC 2018 to discuss ways to bring back pharmaceutical sector in Odisha. Dr. Sruti Renjan Mishra
08:00  [IST]Global pharma cos to shell out more to export products to India as govt raises site registration, inspection fees steeply
more news >>
YESTERDAY'S NEWS
18:00  [IST]Bristol-Myers Squibb's phase 3 CheckMate-331 study does not meet primary endpont
17:20  [IST]Dr Reddy's Laboratories announces sale of its API manufacturing unit in Jeedimetla
17:00  [IST]Bayer's Xarelto receives US FDA nod to treat coronary artery disease
16:10  [IST]Lupin gets US FDA tentative approval for generic lurasidone hydrochloride tablets
15:50  [IST]AiMeD, Busan Technopark ink MoU to boost Indian, Korean medical devices sector
15:40  [IST]Apollo Spectra Hospitals and The Esthetic Clinics collaborate to launch facial plastic and cosmetic surgery
more news >>
INTERVIEW  
Rising burden of NCDs impacts Indian healthcare scene
Gagan Singh Bedi, managing director, AstraZeneca Pharma India Gagan-Singh-Bedi.jpg
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the central govt's decision to replace MCI with National Medical Commission boost the medical education scenario in the country?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
ipc_2018
cphi-india_Banner-150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |